Sensyne Health (LON:SENS) Trading Down 33.3% – Should You Sell?

Sensyne Health PLC (LON:SENSGet Free Report)’s share price fell 33.3% during trading on Wednesday . The company traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). 4,449,142 shares were traded during trading, an increase of 29% from the average session volume of 3,449,819 shares. The stock had previously closed at GBX 0.53 ($0.01).

Sensyne Health Price Performance

The company has a debt-to-equity ratio of 6.02, a current ratio of 2.26 and a quick ratio of 2.26. The stock’s fifty day moving average is GBX 0.35 and its 200-day moving average is GBX 0.35. The stock has a market cap of £582,624.00 and a PE ratio of -0.02.

Sensyne Health Company Profile

(Get Free Report)

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts.

Featured Articles

Receive News & Ratings for Sensyne Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensyne Health and related companies with MarketBeat.com's FREE daily email newsletter.